Why Cell and Gene Therapies Cost So Much – And What Can Be Done
Is Business Broken?
The Disparity in Access to Publicly Funded Therapies
This chapter explores the U.S. government's long-term investment in scientific research and its bipartisan backing, particularly in the realm of cell and gene therapies. It also addresses the inequities in access to these potentially life-saving treatments despite significant public funding.
00:00
Transcript
Play full episode
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
